David Weinberg
Co-Founder and CEO
David Weinberg is the co-founder and CEO of ParcelBio, a next-generation mRNA therapeutics company. He was previously the vice president of RNA Platform at Orbital Therapeutics/Circ Bio, where he led the development of a circular RNA therapeutics platform. Before that, he was the senior director of molecular research at Freenome, where he built the multiomics diagnostics platform that enabled a blood test for the early detection of cancer. David obtained his Ph.D. from MIT, was a UCSF Faculty Fellow, and has been honored with Forbes “30 Under 30” and the NIH Early Independence Award.